What is Burcon?
Founded in 1998 and headquartered in Vancouver, Canada, Burcon operates at the intersection of biotechnology and industrial food production. The company specializes in the development of high-quality, cost-effective plant-based proteins and functional ingredients. Through its extensive patent portfolio, Burcon enables large-scale manufacturers to integrate sustainable, plant-derived components into mainstream consumer products. Its market position is defined by a long-term commitment to research and development, allowing it to navigate the complexities of global food security and the increasing consumer demand for clean-label, sustainable alternatives to traditional animal-based proteins.
How much funding has Burcon raised?
Burcon has raised a total of $14M across 2 funding rounds:
Debt
$10M
Stock/Share Issuance
$4M
Debt (2020): $10M with participation from Agriculture
Stock/Share Issuance (2025): $4M, investors not publicly disclosed
Key Investors in Burcon
Agriculture
An institutional entity focused on the advancement of agricultural technologies and sustainable food production infrastructure.
Undisclosed Investors
What's next for Burcon?
With the recent infusion of capital, Burcon is well-positioned to accelerate its commercialization efforts and expand its manufacturing footprint. The strategic focus will likely shift toward scaling production capacity to meet the rising demand from global food conglomerates seeking to diversify their product offerings. As the company moves into this next phase of growth, it will prioritize operational efficiency and the optimization of its protein extraction processes. Investors and industry analysts will be monitoring Burcon's ability to translate its technological expertise into sustained revenue growth, particularly as the competitive landscape for plant-based ingredients becomes increasingly sophisticated and globalized.
See full Burcon company page
